Inotek Pharmaceuticals Acquires GMP Manufacturing Facility in Israel

Inotek Pharmaceuticals Corporation has acquired a 30,000 square foot GMP manufacturing facility in Dimona, Israel. The manufacturing plant provides Inotek with the ability to manufacture drugs for many of the company's ongoing Phase I and Phase II clinical trials, produce pilot-scale quantities of drug for Inotek's ongoing research and development programs, and potentially provide commercial quantities for approved drugs targeting orphan drug indications.

()a href="http://feeds.bignewsnetwork.com/redir.php?jid=7843707cd5dd6b02&cat=6dcd932030878143" target="_blank">Big News Network